Navigation Links
Hologic to Release Second Quarter Fiscal 2009 Operating Results on Monday, May 4, 2009
Date:3/17/2009

BEDFORD, Mass., March 17 /PRNewswire-FirstCall/ -- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced plans to release its second quarter fiscal 2009 operating results on Monday, May 4, 2009 after market close. In conjunction with the release, management will host a conference call on Monday, May 4, 2009 at 5:00 p.m. (eastern).

Interested participants may listen to the call by dialing 877-852-6575 or 719-325-4832 for international callers and referencing code 8094407 approximately 15 minutes prior to the call on May 4th. For those unable to participate in the live broadcast, a replay will be available one hour after the call ends through Friday, May 15, 2009 at 888-203-1112 or 719-457-0820 for international callers, access code 8094407.

The Company will also provide a live webcast of the call. Interested participants may access the webcast at the Company's website at www.hologic.com. A replay of the call will be archived on the Company's website.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Hologic's core business units are focused on breast health, diagnostics, GYN surgical, and skeletal health. Hologic provides a comprehensive suite of technologies with products for mammography and breast biopsy, radiation treatment for early-stage breast cancer, cervical cancer screening, treatment for menorrhagia, osteoporosis assessment, preterm birth risk assessment, mini C-arm for extremity imaging and molecular diagnostic products including reagents for a variety of DNA and RNA analysis applications. For more information, visit www.hologic.com.

    Contact:  Deborah R. Gordon
              Vice President, Investor Relations
              Hologic, Inc.
              (781) 999-7716

              Frances Doria
              Director, Investor Relations
              Hologic, Inc.
              (781) 999-7377


'/>"/>
SOURCE Hologic, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FDA Approves Two Hologic HPV Tests
2. Compulsive Hoarding Poses Safety and Psychological Risks
3. Teens with cancer present unique psychological issues
4. Pathologically elevated blood fat levels in obesity: Researchers discover molecular causes
5. Psychological impact found in adolescents with kidney transplants
6. Hologic Announces First Quarter Fiscal 2009 Operating Results
7. Health Integrated Unifies Care Community to Improve Physical, Psychological and Social Health of the Chronically Ill
8. Hologic To Provide Business Update at Investor Meeting
9. Hologic, Inc. to Release First Quarter Fiscal 2009 Operating Results on Monday, February 2, 2009
10. Selflessness, core of all major world religions, has neuropsychological connection
11. Hologic to Present at the J.P. Morgan 27th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the ... new design of the shoulder pad. The shoulder pad provides optimal support and ... pain while using cold therapy. By utilizing ice and water that is circulated from ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., a ... today announced that it has been ranked #1 by its ... Book™ Rankings 2017 User Survey. ZirMed was recognized as ... large hospitals and medical centers over 200 beds and holds ... healthcare technology user survey history. ...
(Date:9/12/2017)... , Sept. 12, 2017  Consumer reviews on the independent review ... as the number one company for hearing aids, ranking it higher ... other brands. ... Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides high performance, state-of-the-art, ...
Breaking Medicine Technology: